Sumitomo Pharma Co., Ltd.
Records under this name other than the patents Sumitomo Pharma Co., Ltd. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 138 patents it holds.
Back to Sumitomo Pharma Co., Ltd.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 9,273,148 | Method for Cancer Immunotherapy Formerly held In force · Medium confidence | In force | Medium confidence | |
| US 9,765,114 | Method for cancer immunotherapy Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 8,575,308 | Method for cancer immunotherapy Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 7,939,627 | Peptides Comprising an Epitope of the Wilms Tumor Gene Product Formerly held In force · High confidence | In force | High confidence | |
| US 8,541,544 | Molecular marker for cancer stem cell Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 9,399,760 | Molecular marker for cancer stem cell Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 10,080,776 | Molecular marker for cancer stem cell Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 11,382,952 | Molecular marker for cancer stem cell Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 8,569,353 | Pyrazole Compound Formerly held In force · High confidence | In force | High confidence | |
| US 8,809,383 | Pyrazole Compound Formerly held In force · High confidence | In force | High confidence |